ArticlePharmacoEconomics2013

The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".

Dwayne Boyers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.